Company: INDP
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001641172-25-023333
Chunk: 5

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 8
Chunk 5
---

  
    Additions 
     5,714,800 
  
    Change in fair value 
     787,703 
  
    Fair value, June 30, 2025 
    $6,502,503 

Recently
issued accounting pronouncements

In November
2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures. This ASU
will require entities to provide enhanced disclosures, in a tabular format, related to certain expense categories included in the statement
of operations. The ASU aims to increase transparency and provide investors with more detailed information about the nature of expenses
reported on the face of the income statement. The new ASU is effective for annual reporting periods beginning after December 15, 2026
and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the
impact of the adoption of this standard on the related disclosures.

In
December 2023, the FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures. This ASU does not change accounting for income
taxes but requires new disclosures focusing on two areas, the effective rate reconciliation and taxes paid. This new standard is effective
for public business entities for annual periods beginning after December 15, 2024. Early adoption is permitted. 

NOTE
3: PREPAID EXPENSES AND OTHER CURRENT ASSETS

Prepaid
expenses and other current assets were comprised of the following:

SCHEDULE OF PREPAID EXPENSE AND OTHER CURRENT ASSETS 

    June 30, 2025  
    December 31, 2024 
  
    Prepaid insurance 
    $83,698  
    $506,489 
  
    Prepaid research and development 
     2,700  
     150,000 
  
    Other prepaid expenses 
     168,959  
     175,088 
  
    Total prepaid expenses and other current assets 
    $255,357  
    $831,577 
  
    Prepaid
    expenses and other current assets 
    $255,357  
    $831,577 

NOTE
4: ACCOUNTS PAYABLE AND OTHER CURRENT LIABILITIES

Accounts
payable and other current liabilities were comprised of the following:

SCHEDULE OF ACCOUNTS PAYABLE AND OTHER CURRENT LIABILITIES